| |
|
|
|
TRACON Pharmaceuticals Inc.  
|
|
2.225 0.025 (0.01%) |
09-20 16:00 |
|
Open: |
2.25 |
Pre close: |
2.2 |
Target:
|
2.74 
|
|
High: |
2.35 |
Low: |
2.2 |
Resistance:
|
2.35
2.74
|
|
Volume: |
114,570 |
Market Cap: |
66M |
Support:
|
2.07
1.90
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.22
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
2.15 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.46 |
Stochastic Oscillator |
%K(14,3):
|
71.43 |
|
MA(250): |
2.70 |
%D(3): |
73.81 |
|
Average Volume(K) |
3-Month: |
8314
|
52-Week |
High:
|
3.91 |
|
10-Days: |
7848 |
Low: |
1.90 |
|
RSI |
RSI(14):
|
52.21 |
Change(%): |
-38.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.090 |
Return on Equity (ttm) |
-86.0 |
Shares Out. (M) |
29.84 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-53.1 |
Shares Float (M) |
29.66 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
31.20 |
|
Forward EPS |
-1.527 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
206 |
|
Book Value (p.s.) |
1.780 |
EBITDA (p.s.) |
0.047 |
P/E |
-2.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.25 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.40 |
P/S |
130184304.00 |
|
Operating Margin |
-218.00 |
Levered Free Cash Flow
(M) |
-8.96 |
P/CF |
-3.82 |
|
|
|
|
|
|
